Astragaloside II
Astragaloside II is an effective MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy. Astragaloside II also induces osteogenic activities, differentiation, proliferation, and mineralization, through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways.
Product Specifications
CAS Number
84676-89-1
Product Name Alternative
Astrasieversianin VIII
Purity
>98% (HPLC)
Solubility
DMSO : 100 mg/mL 120.92 mM; H2O : < 0.1 mg/mL
Smiles
C (=O) (C) O[C@H]1[C@@H] (OC[C@H] ([C@@H]1O) O) O[C@H]1CC[C@]23C4 (CC[C@]5 ([C@] ([C@@H]4C[C@@H] ([C@H]2C1 (C) C) O[C@H]1[C@@H] ([C@H] ([C@@H] ([C@H] (O1) CO) O) O) O) (C[C@@H] ([C@@H]5[C@@]1 (O[C@@H] (CC1) C (C) (C) O) C) O) C) C) C3
Molecular Formula
C41H66O15
Molecular Weight
798.95
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
M01324-3 100 µg
Anti-NRP1 / VEGF165R / CD304 Reference Antibody (vesencumab)
Sign In for Pricing
View Details 
